Acidophil team members will attend the World Anti-Microbial Resistance (AMR) Congress 2019 in Washington D.C., a two-day event (Nov. 7-8) bringing biotech companies, universities, hospitals, foundations, and government agencies together in the fight against AMR. If you are attending the conference, send an email to mbwickless@acidophil.com – we would love to meet you! […]
New Leadership Addition to AgriMetis® Team
LUTHERVILLE, MD – August 12, 2019 – AgriMetis, LLC is pleased to announce that Dr. Andrew Plant joined the AgriMetis team as Chief Technology Officer (CTO) in July 2019. Dr. Plant previously held various global research and development (R&D) leadership positions within crop protection companies Bayer and Syngenta, as well as Merck Animal Health. Dr. […]
AgriMetis® Receives Second US Patent to Produce More Technologically Advanced, Safer Tool Against Weeds
LUTHERVILLE, MD – May 8, 2019 – AgriMetis, LLC is pleased to announce the issuance of a second US patent related to L-glufosinate (Glu-L™). This second patent is part of the Glu-L product family of broad-spectrum herbicides offering an improved alternative to the commercial racemic glufosinate currently offered in the agricultural market. With issuance of […]
Current Focus: Evobiotics
Evobiotics was founded in 2016 with the purpose of discovering and developing novel antimicrobial compounds to treat bacterial and fungal infections in humans. It is currently funded by seed capital from Acidophil to support the research and development activities of its two lead programs, and is actively looking to in-license additional programs. […]
AgriMetis® Expands Through Addition of Field Biology Expertise
LUTHERVILLE, MD – March 11, 2019 – AgriMetis, LLC, is pleased to announce Dr. Thomas Hayden has joined the company as Field Biology Lead. Dr. Hayden is welcomed by a growing team of industry veterans who are working to discover, develop, and deliver innovative crop protection compounds to the industry. View the AgriMetis team here: […]
New Addition to AgriMetis® Scientific Advisory Board Enhances Powerhouse in Research & Development
LUTHERVILLE, MD – February 19, 2019 – AgriMetis, LLC, is pleased to announce Dr. Adrian Percy joined the scientific advisory board (SAB) on February 1, 2019. Dr. Percy is welcomed by a renowned group of advisors who have come to AgriMetis after holding technical/science leadership positions within other major agricultural companies, such as Bayer Crop […]
AgriMetis™ Announces Second International Patent Filing to Provide Farmers Safer, Improved Tool Against Weeds
LUTHERVILLE, MD – February 11, 2019 – AgriMetis, LLC is pleased to announce that a second international patent cooperation treaty (PCT) filing related to its L-glufosinate (Glu-L™) program has been published. The Glu-L product family of broad-spectrum herbicides offers an improved alternative to the commercial racemic glufosinate currently being manufactured and sold, marking a milestone […]
AgPitch18 names AgrIMetis as finalist in their top five emerging companies
AgPitch18 Finalist – AgriMetis The world needs a more innovative approach to combining both biology and chemistry to make novel, effective chemical structures that can lower production costs and/or increase food output. It typically takes hundreds of millions of dollars for traditional agricultural chemical companies (ag chem) to discover, develop and deliver one ag chem product. […]
CHALANTE TO PRESENT AT AGRI-TECH INVESTMENT SHOWCASE
Chalante has been selected to present at the World Agri-Tech Innovation Summit in London on the 16th and 17th of October 2018. They are one of six companies chosen to showcase their technology or solution to the audience of global agribusinesses, technology integrators, and VC investors. Chalante’s presentation will be given by Dr. Simon Aspland, General […]
CHALANTE TO PRESENT AT ANIMAL HEALTH INVESTMENT FORUM
Chalante has been selected to present at the Animal Health Investment Forum in Kansas City (USA) on August 21st, 2018. They are one of 12 emerging animal health and nutrition companies chosen to present their innovative programs to a panel of industry experts. Chalante’s presentation will be given by Dr. Simon Aspland, General Manager. More […]